Alerts will be sent to your verified email
Verify Email
GUFICBIO
|
Gufic Biosciences
|
Zota Health Care
|
Orchid Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
25.05 % | -1.91 % | 0.86 % |
|
5yr Avg Net Profit Margin
|
10.9 % | -0.52 % | 0.56 % |
|
Price to Book
|
6.06 | 16.38 | 2.89 |
|
P/E
|
58.83 | 0.0 | 43.03 |
|
5yr Avg Cash Conversion Cycle
|
26.94 Days | 38.95 Days | 52.03 Days |
|
5yr Average Interest Coverage Ratio
|
13.1 | 18.17 | 3.01 |
|
5yr Avg ROCE
|
27.25 % | 1.25 % | 3.08 % |
|
5yr Avg Operating Profit Margin
|
18.45 % | 5.05 % | 11.84 % |
|
5 yr average Debt to Equity
|
0.51 | 0.03 | 0.37 |
|
5yr CAGR Net Profit
|
14.26 % | n/a | n/a |
|
5yr Average Return on Assets
|
11.52 % | -0.16 % | 1.2 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.52 % | 57.42 % | 69.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.26 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.48 % | -10.7 % | -20.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.35 % | 0.0 | 16.13 % |
|
Gufic Biosciences
|
Zota Health Care
|
Orchid Pharma
|
|---|